Acceptance of Traditional Chinese Medicines in Patients with Ulcerative Colitis: a Multicenter Cross-Sectional Study

doi:10.19803/j.1672-8629.20240212

Abstract

Abstract: Objective To assess the level of acceptance of traditional Chinese medicine (TCM) among outpatients with ulcerative colitis (UC) and to find out what shapes their decision to accept or decline TCM treatment. Methods A survey was conducted among UC outpatients at various hospitals in Beijing. The collected data was analyzed using Statistical Package for the Social Sciences (SPSS) version 26.0. Results The survey yielded 236 questionnaires, with 208 valid responses. The median age of the participants was 40 years (interquartile range: 32, 50), comprising 123 males (59.13%) and 85 females (40.87%). Multivariable logistic regression revealed that gender [Odds Ratio (OR)=2.53, 95%CI: 1.07~6.01], prior use of Wuweikushen capsules (OR=5.08, 95%CI: 1.05~24.67), and the lack of compliance within the past two weeks (OR=0.27, 95%CI: 0.09~0.82) were significantly correlated with the acceptance of TCM for UC treatment (P<0.05). Among the participants, A questionnaire analysis was conducted to examine the reasons why patients were willing or unwilling to accept TCM treatment. The results showed that among the 175 patients who were willing to receive TCM treatment, the majority chose it primarily because of its fewer adverse effects. In contrast, among the 33 patients. Conclusion Gender and past medication experiences make a huge difference to the acceptance of TCM treatments among UC patients. In addition, medication compliance and the affordability of TCM are also focuses of attention in clinical practice.

Key words: Ulcerative Colitis, Wuweikushen Capsules, Price of TCM, Medication Compliance, Acceptance of TCM, Multi-variable Logistic Regression Analysis

CLC Number:

BU Zhijun, LIU Fang, HOU Wenbin, SU Juanping, LIU Yandi, SU Xiaolan, WANG Jianyun, LI Junxiang, SUN Yuxin, CHEN Yunru, ZHENG Youyou, WANG Xuehui, LIU Fengshuang, TIAN Yuanchun, LIU Jianping, LIU Zhaolan. Acceptance of Traditional Chinese Medicines in Patients with Ulcerative Colitis: a Multicenter Cross-Sectional Study[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 183-187.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/10.19803/j.1672-8629.20240212

https://zgywjj.magtechjournal.com/EN/Y2025/V22/I2/183

References

[1] FEUERSTEIN JD, MOSS AC, FARRAYE FA.Ulcerative Colitis[J]. Mayo Clinic Proceedings, 2019, 94(7): 1357-1373.
[2] NG SC, SHI HY, HAMIDI N, et al.Worldwide Incidence and Prevalence of Inflammatory Bowel Disease in the 21st Century: A Systematic Review of Population-Based Studies[J]. Lancet, 2017, 390(10114): 2769-2778.
[3] KAPLAN GG.The Global Burden of IBD: from 2015 to 2025[J]. Nature Reviews Gastroenterology & Hepatology, 2015, 12(12): 720-727.
[4] LE BERRE C, HONAP S, PEYRIN-BIROULET L.Ulcerative Colitis[J]. Lancet, 2023, 402(10401): 571-584.
[5] JING SS, HE ZQ, ZHENG X, et al.Research Progress on Metabolomics of TCM Treatment of Ulcerative Colitis[J]. Acta Chinese Medicine(中医学报), 2023, 38(7): 1386-1394.
[6] YU JJ, ZHANG LY, LIU ES, et al.Overview of Adverse Reactions to Sulfasalazine: A Literature Review[J]. Chinese Journal of Drug Abuse Prevention and Treatment(中国药物滥用防治杂志) , 2016, 22(4): 242-243.
[7] LI MT, LI H, ZHU LL, et al.Therapeutic Response to Glucocorticoids and Predictive Factors in Severe Ulcerative Colitis[J]. Chinese Journal of Gastroenterology(胃肠病学), 2019, 24(7): 395-399.
[8] YANG QQ, ZHOU JB, CAI S, et al.Feasibility Analysis of the Efficacy and Adverse Reactions of Azathioprine in the Treatment of Ulcerative Colitis and Crohn's Disease[J]. Chinese Remedies & Clinics(中国药物与临床), 2018, 18(10): 1739-1741.
[9] ZHANG SS, ZHAO LQ.Review of Research Progress on Traditional Chinese Medicine in the Treatment of Ulcerative Colitis[J]. Beijing Journal of Traditional Chinese Medicine(北京中医药), 2022, 41(9): 944-950.
[10] SHEN H, ZHANG S, ZHAO W, et al.Randomised Clinical Trial: Efficacy and Safety of Qing-Chang-Hua-Shi Granules in a Multicenter, Randomized, and Double-Blind Clinical Trial of Patients with Moderately Active Ulcerative Colitis[J]. Biomedicine & Pharmacotherapy, 2021, 139: 111580.
[11] WANG ZB, CHEN C, GUO Y, et al.Therapeutic Analysis of Qingchang Wenzhong Formula for Treatment of Mild-Moderate Ulcerative Colitis Patients[J]. Chinese Journal of Integrated Traditional and Western Medicine(中国中西医结合杂志), 2018, 38(1): 15-19.
[12] WANG Z, CHEN Q, KONG B, et al.Effects of Modified Gegen Qinlian Decoction Combined with Probiotics on IL-6, IL-1, IL-10 and TGF-β in Serum of Patients with Ulcerative Colitis[J]. Chinese Archives of Traditional Chinese Medicine(中华中医药学刊), 2022, 40(3): 248-251.
[13] QI Q, IM H, LI K S, et al.Influence of Herb-Partitioned Moxibustion at Qihai (CV6) and Bilateral Tianshu (ST25) and Shangjuxu (ST37) Acupoints on Toll-Like Receptors 4 Signaling Pathways in Patients with Ulcerative Colitis[J]. Journal of Traditional Chinese Medicine, 2021, 41(3): 479-485.
[14] MOSS, AC.Curcumin for Maintenance Therapy in Ulcerative Colitis[J]. Clinical Gastroenterology & Hepatology, 2007, 5(5): 642-642.
[15] WU KC, LIANG J, RAN ZH, et al.Chinese Consensus on Diagnosis and Treatment of Inflammatory Bowel Disease(Beijing, 2018)[J]. Chinese Journal of Practical Internal Medicine(中国实用内科杂志), 2018, 38(9): 796-813.
[16] MAO LQ, LI XH, ZHANG XD, et al.Analysis of the Demand for TCM Services Among Physical Examination Populations in a Hospital in Shanghai[J]. Medicine and Society(医学与社会), 2019, 32(4): 6-8, 19.
[17] XIONG JB, LI Z, WU JJ, et al.Effect and Mechanism of Five-Flavor Sophora Flavescens Enteric-Coated Capsules on Rats with Ulcerative Colitis[J]. Zhejiang Medicine(浙江医学), 2024, 46(5): 464-469, 562.
[18] DENG T, LIU JX.Clinical Effect of Guben Yichang Tablets Combined with Mesalazine Enteric Coated Tablets in Treatment of Ulcerative Colitis and its Influences on Immune Function and Serum sRAGE and Vaspin[J]. Clinical Medical Research and Practice(临床医学研究与实践), 2023, 8(6): 115-118.
[19] YIN EQ, LIU Y, ZHENG YJ.Effects of Guben Yichang Tablets Combined with Mesalazine Enteric-Coated Tablets on Serum Inflammatory Factors and Immune Function in Patients with Ulcerative Colitis[J]. Heilongjiang Medical Journal(黑龙江医药), 2022, 35(6): 1336-1338.
[20] CAI CQ.Clinical Efficacy of Mesalazine Tablets Combined with Suppositories in the Treatment of Left-Sided Ulcerative Colitis[J]. Chinese Journal of Clinical Rational Drug Use(临床合理用药), 2023, 16(9): 93-95.
[21] YANG ZH, TIAN K, YANG Y, et al.Analysis of Factors Affecting the Acceptance of TCM Services in Jiangsu and Gansu Regions[J]. Chinese Health Service Management(中国卫生事业管理), 2018, 35(1): 32-35.
[22] ZHU MD, WANG JY, TAO SS, et al.Study on the Trust in TCM Services and Its Influencing Factors in Jiangxi Province[J]. Chinese Health Service Management(中国卫生事业管理), 2020, 37(4): 287-290, 293.
[23] KONTOLA K, OKSANEN P, HUHTALA H, et al.Increasing Incidence of Inflammatory Bowel Disease, with Greatest Change among the Elderly: a Nationwide Study in Finland, 2000-2020[J]. Journal of Crohn’s & Colitis, 2023, 17(5): 706-711.
[24] MOLODECKY NA, SOON IS, RABI DM, et al.Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases with Time, Based on Systematic Review[J]. Gastroenterology, 2012, 142(1): 46-54.
[25] QI YH, ZHANG X, CAO Q, et al.Investigation of the Utility and Recognition of Traditional Chinese Medicine Services in Jiangsu Province and the Strategy[J]. Chinese General Practice(中国全科医学), 2010, 13(7): 748-750.
[26] WU YL.Curbing the Rapid Price Increase of Chinese Herbal Medicines and Protecting the Traditional Chinese Medicine Industry[J]. China Food and Drug Administration(中国食品药品监管), 2015(3): 16.
[27] FU J, WANG YY, ZHANG YY, et al.Progress of Traditional Chinese Medicine in the Treatment of Ulcerative Colitis[J]. Bachu Medical Journal(巴楚医学), 2023, 6(1): 108-111.
[28] ZHOU CY, DAI YY, WANG BY, et al.Research Progress of Gegen Qinlian Decoction in the Treatment of Ulcerative Colitis. Journal of Liaoning University of TCM(辽宁中医药大学学报), 2024, 26(4): 179-184.
[29] MAO LQ, LI XH, ZHANG X, et al.Analysis of the Demand for TCM Services Among Physical Examination Populations in a Hospital in Shanghai[J]. Medicine and Society(医学与社会), 2019, 32(4): 6-8, 19.